Cargando…
H. pylori Eradication Treatment Causes Alterations in the Gut Microbiota and Blood Lipid Levels
Background: The gut microbiome plays an important role in the lipid metabolism. Antibiotic treatment causes changes in the intestinal microbiota. Our objective was to explore the relationship between changes in the intestinal microbiota and the level of plasma high density lipoprotein cholesterol (H...
Autores principales: | Martín-Núñez, Gracia M., Cornejo-Pareja, Isabel, Roca-Rodríguez, M. del Mar, Clemente-Postigo, Mercedes, Cardona, Fernando, Fernández-García, José C., Moreno-Indias, Isabel, Tinahones, Francisco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431686/ https://www.ncbi.nlm.nih.gov/pubmed/32850910 http://dx.doi.org/10.3389/fmed.2020.00417 |
Ejemplares similares
-
Helicobacter pylori Eradication Therapy Affect the Gut Microbiota and Ghrelin Levels
por: Martín-Núñez, Gracia Mª, et al.
Publicado: (2021) -
H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota
por: Martín-Núñez, Gracia Mª, et al.
Publicado: (2019) -
Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?
por: Martin-Nuñez, Gracia M., et al.
Publicado: (2021) -
H. pylori Eradication Treatment Alters Gut Microbiota and GLP-1 Secretion in Humans
por: Cornejo-Pareja, Isabel, et al.
Publicado: (2019) -
Metabolic and Endocrine Consequences of Bariatric Surgery
por: Cornejo-Pareja, Isabel, et al.
Publicado: (2019)